Relative Bioavailability of Single Doses of Dabigatran Etexilate in Healthy Volunteers

NCT02173717 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Dabigatran etexilate
DRUG: Rifampicin

Sponsor

Boehringer Ingelheim